Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New approaches for developing biomarkers of hormonal contraceptive use. | Sci Rep | 2023 | 36604469 | PubTator, text mining | PubMed |
| Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation. | Cell Prolif | 2023 | 36547008 | PubTator, text mining | PubMed |
| Specific mechanisms of translation initiation in higher eukaryotes: the eIF4G2 story. | RNA | 2023 | 36517212 | PubTator, text mining | PubMed |
| New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians. | Respiration | 2023 | 36516792 | PubTator, text mining | PubMed |
| Accuracy of Rapid Emergency Medicine Score and Sequential Organ Failure Assessment Score in predicting acute paraphenylenediamine poisoning adverse outcomes. | Environ Sci Pollut Res Int | 2023 | 36462082 | PubTator, text mining | PubMed |
| Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis. | Digestion | 2023 | 36366816 | PubTator, text mining | PubMed |
| Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine. | Clin Cancer Res | 2023 | 36346687 | PubTator, text mining | PubMed |
| Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells. | J Cancer Res Clin Oncol | 2023 | 36329350 | PubTator, text mining | PubMed |
| Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. | Cancer Res | 2023 | 36318118 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances. | Arch Toxicol | 2023 | 36138126 | PubTator, text mining | PubMed |
| Quantification of spatial pharmacogene expression heterogeneity in breast tumors. | Cancer Rep (Hoboken) | 2023 | 35906899 | PubTator, text mining | PubMed |
| Study on the reduction of heterocyclic amines by marinated natural materials in pork belly. | J Anim Sci Technol | 2022 | 36812002 | PubTator, text mining | PubMed |
| Identification of lymph node metastasis-related genes and patterns of immune infiltration in colon adenocarcinoma. | Front Oncol | 2022 | 36727052 | PubTator, text mining | PubMed |
| Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer. | Int J Mol Sci | 2022 | 36555156 | PubTator, text mining | PubMed |
| Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis. | Genes (Basel) | 2022 | 36553594 | PubTator, text mining | PubMed |
The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial. | Trials | 2022 | 36544211 | PubTator, text mining | PubMed |
| The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review. | Cancers (Basel) | 2022 | 36497451 | PubTator, text mining | PubMed |
| Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study. | Cancers (Basel) | 2022 | 36497361 | PubTator, text mining | PubMed |
| Home bias and employee social responsibility: Identification vs. benefit exchange. | PLoS One | 2022 | 36480576 | PubTator, text mining | PubMed |
| Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans. | Genome Biol Evol | 2022 | 36445690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=7